Note: Ingredients listed on restricted chemical lists
EC/CAS
919-30-2
Name of the chemical
3-aminopropyltriethoxysilane
Concentration
N/A
EC/CAS
96-29-7
Name of the chemical
2-Butanonoxim (2020/1182)
Concentration
N/A
EC/CAS
202-496-6
Name of the chemical
2-Butanonoxim (2020/1182)
Concentration
N/A
General Information
Revision date
2020-06-05
Product name
Drei Bond 1209
Emergency telephone
GIZ-Nord, Göttingen, Germany,
Icons in SDS
Company Information
company name
Drei Bond GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@dreibond.de, datenblaetter@dreibond.de
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H317, H319
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
CLP CLASSIFICATION
Skin Irrit. 2; H315 Causes skin irritation. Eye Irrit. 2; H319 Causes serious eye irritation. Skin Sens. 1; H317 May cause an allergic skin reaction.
2.2 Label elements
CLP)
Signal word
Warning
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation.
Precautionary statements
P280 Wear protective gloves/protective clothing/eye protection. P333+P337+P313 If skin irritation or rash occurs or If eye irritation persists: Get medical advice/attention. P363 Wash contaminated clothing before reuse. Special labelling Text for labelling:
Contains
Butan-2-one O,O',O''-(methylsilylidyne)trioxime, 3-Aminopropyltriethoxysilane, Butan-2-one O,O',O''-(vinylsilylidyne)trioxime and 2-Butanone oxime (MEKO).
2.3 Other hazards
Hydrolysis product(s): under the influence of moisture, product segregates small quantities of butanone-2-oxim (CAS 96-29-7). This can cause irritation of the eyes and sensitizing. Long-term exposure to MEKO may damage the mucous membrane of the nose. Long-term high dose inhalation of MEKO may cause irreversible damage to health. Special danger of slipping by leaking/spilling product.
Results of PBT and vPvB assessment
This substance does not meet the PBT/vPvB criteria of REACH, Annex XIII.